by Jordana Choucair | Nov 17, 2021 | Life Sciences
The Biden administration plans to pay more than $5 billion for a stockpile of Pfizer’s new COVID-19 pill, enough for about 10 million courses of treatment to be delivered in the next 10 months. Senior federal health officials are counting on the five-day antiviral...
by Jordana Choucair | Nov 17, 2021 | Life Sciences
The FDA’s committee of outside experts is not planning to meet to discuss the data on Pfizer’s request for the agency to authorize COVID-19 boosters for all adults. The panel twice voted to reject boosters for the young and healthy who don’t face high exposure risks....
by Jordana Choucair | Nov 17, 2021 | Health IT
Quest Diagnostics released its 2021 Health Trends report, revealing that providers are concerned that substance use disorder issues are slipping through the cracks in virtual care. Only half of the 500 physicians surveyed said they feel confident that they can...
by Jordana Choucair | Nov 17, 2021 | D.C. News
The Biden administration filed a request to consolidate the 34 lawsuits against the administration’s vaccine and testing requirements. As a result, the Sixth Circuit will decide whether to permanently halt the mandate. A variety of plaintiffs — including Republican...
by Jordana Choucair | Nov 16, 2021 | D.C. News
President Biden is facing a congressional deadline today to nominate an official to serve as the assistant secretary for the Administration for Children and Families at HHS. In addition to managing the nation’s Head Start program for low-income children, welfare, and...
by Jordana Choucair | Nov 16, 2021 | Life Sciences
Pfizer has agreed to a licensing deal with the U.N.’s Medicines Patent Pool for its COVID-19 pill. Under the agreement, Pfizer will manufacture and supply its effective antiviral pill in 95 countries, including all low-income and lower-middle-income nations. The...
Recent Comments